Wednesday, July 8, 2026

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi

1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Clinical program

Simvastatin

Phase 1 · small molecule · Recurrent Acute Pancreatitis

Simvastatin for Recurrent Acute Pancreatitis is a Phase 1 program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Internal code STUDY00002293

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
United Therapeutics Europe Ltd
Phase
Phase 1
Modality
small_molecule
Indication
Recurrent Acute Pancreatitis
Status
active
Trials
1